Results of the Czech National Colorectal Cancer Screening Programme – Colonoscopy Examinations

Česká verzia

Authors: Š. Suchánek ¹; O. Májek ^2,3; M. Zavoral ³; B. Seifert ⁴; O. Ngo ²; L. Dušek ^2,3
Authors place of work: Interní klinika 1. LF UK a ÚVN Praha ¹; Institut bio statistiky a analýz, LF a PřF MU, Brno ²; Ústav zdravotnických informací a statistiky ČR, Praha ³; Ústav všeobecného lékařství, 1. LF UK v Praze ⁴
Published in the journal: Klin Onkol 2014; 27(Supplementum 2): 98-105
doi: https://doi.org/10.14735/amko20142S98

Summary

Introduction:
Colorectal cancer (CRC) is one of the most common cancers, and the Central European countries have the highest CRC burden worldwide. CRC screening has repeatedly been proven capable of decreasing CRC mortality and incidence rates. The nationwide Colorectal Cancer Screening Programme in the Czech Republic involves the colonoscopic examination as a diagnostic method (for patients with a positive FOBT result – screening colonoscopy – SC), or as a screening method (primary screening colonoscopy – PSC). The aim of this article is to present the results of colonoscopic examinations performed as part of the Czech screening programme.

Material and Methods:
For the purpose of quality assurance, the Czech programme has been equipped since 2006 with an information system called the Colorectal Cancer Screening Registry, which collects and evaluates data on preventive colonoscopies performed in the colonoscopy screening centres. Performance indicators, as specified in the European Guidelines (and adapted for the Czech programme), are employed to assess preventive colonoscopies performed in the Czech Republic.

Results:
Since 2006, more than 110,000 SCs and almost 20,000 PSCs were recorded. Approximately 95% of SCs and almost 98% of PSC were classified as total, i.e. examining the entire colonic mucosa up to the caecum. The positive predictive value of FOBT for adenomas has increased slightly and continuously over time, and was 39.7% in 2013. In PSC, the adenoma detection rate (ADR) has recently increased compared to previous years, and was 27.3% in 2013. CRC was detected in 3.7% of individuals undergoing an SC examination and in 1.0% of individuals undergoing a PSC examination. The programme safety is controlled based on the monitoring of complications during colonoscopies; these can occur either during diagnostic colonoscopy (perforation in 0.03% of cases since 2006) or during endoscopic polypectomy (perforation in 0.12% of cases, bleeding in 0.73% of cases since 2006).

Conclusion:
Our results confirm that the quality of colonoscopic examinations corresponds to the international standards and that this is not an obstacle to a positive impact of CRC screening on the Czech population, which has a high colorectal cancer burden.

Key words:
colorectal neoplasms – mass screening – colonoscopy – quality indicators – health care

This study was supported by the project 36/14/NAP “Development and implementation of methodology for the evaluation of effectiveness of personalised invitations of citizens to cancer screening programmes” as part of the programme of the Czech Ministry of Health “National action plans and conceptions”.

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

Submitted:
12. 9. 2014

Accepted:
17. 10. 2014

Zdroje

1. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [monograph on the Internet]. Lyon: International Agency for Research on Cancer; 2013 [cited 2014 Jun 18]. Available from: http:/ / globocan.iarc.fr.

2. World Cancer Research Fund/ American Institute for Cancer Research, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington DC: AICR 2007.

3. Hewitson P, Glasziou P, Watson E et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008; 103(6): 1541−1549. doi: 10.1111/ j.1572‑ 0241.2008.01875.x.

4. Brenner H, Altenhofen L, Hoffmeister M. Estimated long‑term effects of the initial 6 years of the German screening colonoscopy program. Gastrointest Endosc 2010; 72(4): 784−789. doi: 10.1016/ j.gie.2010.06.017.

5. Council recommendation of 2 December 2003 on cancer screening (2003/ 878/ EC) [Internet] [cited 2012 Sep 28]. Available from: http:/ / eur‑ lex.europa.eu/ LexUriServ/ LexUriServ.do?uri=OJ:L:2003:327:0034:0038:EN:PDF.

6. Zavoral M, Suchanek S, Majek O et al. Colorectal cancer screening: 20 years of development and recent progress. World J Gastroenterol 2014; 20(14): 3825−3834. doi: 10.3748/ wjg.v20.i14.3825.

7. Standard při poskytování a vykazování výkonů screeningu nádorů kolorekta v České republice, Věstník MZ ČR, částka 01/ 2009: 20– 23.

8. Zavoral M, Májek O, Tachecí I et al. Porovnání účinnosti kolonické kapslové endoskopie a kolonoskopie v detekci polypů a karcinomů tlustého střeva a konečníku − multicentrická, prospektivní cross‑ over studie. Gastroent Hepatol 2014; 68(3): 218−224.

9. Lieberman DA, Rex DK, Winawer SJ et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi‑Society Task Force on Colorectal Cancer. Gastroenterology 2012; 143(3): 844−857. doi: 10.1053/ j.gastro.2012.06.001.

10. Rembacken B, Hassan C, Riemann JF et al. Quality in screening colonoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE). Endoscopy 2012; 44(10): 957−968. doi: 10.1055/ s‑ 0032‑ 1325686.

11. Segnan N, Patnick J, von Karsa L (eds). European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Publications Office of the European Union 2010.

12. Lieberman D, Nadel M, Smith RA et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc 2007; 65(6): 757−766.

13. Kolorektum.cz [internetová stránka]. Screening kolorektálního karcinomu. Program kolorektálního screeningu v České republice. Brno: Masarykova univerzita; 2012. Dostupné z: http:/ / www.kolorektum.cz.

14. Moss S, Ancelle‑ Park R, Brenner H. Evaluation and interpretation of screening outcomes. In: Segnan N, Patnick J, von Karsa L (eds). European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Publications Office of the European Union 2010.

15. Suchanek S, Majek O, Vojtechova G et al. Colorectal cancer prevention in the Czech Republic: time trends in performance indicators and current situation after 10 years of screening. Eur J Cancer Prev 2014; 23(1): 18−26. doi: 10.1097/ CEJ.0b013e328364f203.

16. Mansmann U, Crispin A, Henschel V et al. Epidemiology and quality control of 245 000 outpatient colonoscopies. Dtsch Arztebl Int 2008; 105(24): 434−440. doi: 10.3238/ arztebl.2008.0434.

17. Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362(19): 1795−1803. doi: 10.1056/ NEJMoa0907667.

18. Seeff LC, Nadel MR, Klabunde CN et al. Patterns and predictors of colorectal cancer test use in the adult US population. Cancer 2004; 100(10): 2093−2103.

19. Wexner SD, Beck DE, Baron TH et al. A consensus document on bowel preparation before colonoscopy: prepared by a Task Force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopoy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Surg Endosc 2006; 20(7): 1161.

20. Church JM. Effectiveness of polyethylene glycol antegrade gut lavage bowel preparation for colonoscopy −timing is the key! Dis Colon Rectum 1998; 41(10): 1223−1225.

21. Hendry PO, Jenkins JT, Diament RH. The impact of poor bowel preparation on colonoscopy: a prospective single centre study of 10,571 colonoscopies. Colorectal Dis 2007; 9(8): 745−748.

22. Atkin W, Valori R, Kuipers E et al. Colonoscopic surveillance after adenoma removal. In: Segnan N, Patnick J,von Karsa L (eds). European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. Luxembourg: Publications Office of the European Union 2010.

23. Rex DK. Quality in colonoscopy: cecal intubation first, then what? Am J Gastroenterol 2006; 101(4): 732−734.

24. Rex DK, Bond JH, Winawer S et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi‑Society Task Force on Colorectal Cancer. Am J Gastroenterol 2002; 97(6): 1296−1308.

25. Panteris V, Haringsma J, Kuipers EJ. Colonoscopy perforation rate, mechanisms and outcome: from diagnostic to therapeutic colonoscopy. Endoscopy 2009; 41(11): 941−951. doi: 10.1055/ s‑ 0029‑ 1215179.

26. Pox CP, Altenhofen L, Brenner H et al. Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology 2012; 142(7): 1460−1467. doi: 10.1053/ j.gastro.2012.03.022.

27. Brenner H, Hoffmeister M, Brenner G et al. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur J Cancer 2009; 45(11): 2027−2033. doi: 10.1016/ j.ejca.2009.02.017.

28. Weller D, Coleman D, Robertson R et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007; 97(12): 1601−1605.

29. Regula J, Rupinski M, Kraszewska E et al. Colonoscopy in colorectal‑ cancer screening for detection of advanced neoplasia. N Engl J Med 2006; 355(18): 1863−1872.

30. Peris M, Espinàs JA, Muñoz L et al. Lessons learnt from a population‑based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screen 2007; 14(2): 81−86.